NPs Basic Information

Name
asperlention D
Molecular Formula C34H32O15
IUPAC Name*
methyl4-acetyloxy-1,8-dihydroxy-5-[5-hydroxy-2-methoxycarbonyl-7-methyl-4-oxo-2-(5-oxooxolan-2-yl)-3H-chromen-6-yl]-3-methyl-9-oxo-3,4-dihydro-2H-xanthene-4a-carboxylate
SMILES
COC(=O)C1(C2CCC(=O)O2)CC(=O)c2c(cc(C)c(-c3ccc(O)c4c3OC3(C(=O)OC)C(=C(O)CC(C)C3OC(C)=O)C4=O)c2O)O1
InChI
InChI=1S/C34H32O15/c1-13-11-20-24(19(38)12-33(48-20,31(42)44-4)21-8-9-22(39)47-21)27(40)23(13)16-6-7-17(36)25-28(41)26-18(37)10-14(2)30(46-15(3)35)34(26,32(43)45-5)49-29(16)25/h6-7,11,14,21,30,36-37,40H,8-10,12H2,1-5H3/t14-,21-,30-,33?,34+/m0/s1
InChIKey
WAVXQOUDBSYDAC-YAZPYZJBSA-N
Synonyms
NA
CAS NA
PubChem CID NA
ChEMBL ID NA
*Note: the IUPAC Name was calculated by STOUT. Reference: PMID:33906675.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Benzopyrans
        • Subclass: 1-benzopyrans
          • Direct Parent: Xanthones

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 680.62 ALogp: 2.9
HBD: 3 HBA: 15
Rotatable Bonds: 5 Lipinski's rule of five: Rejected
Polar Surface Area: 218.5 Aromatic Rings: 6
Heavy Atoms: 49 QED Weighted: 0.303

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.2 MDCK Permeability: 0.00003080
Pgp-inhibitor: 0.896 Pgp-substrate: 0.251
Human Intestinal Absorption (HIA): 0.746 20% Bioavailability (F20%): 0.01
30% Bioavailability (F30%): 0.888

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.012 Plasma Protein Binding (PPB): 87.43%
Volume Distribution (VD): 0.563 Fu: 5.66%

ADMET: Metabolism

CYP1A2-inhibitor: 0.018 CYP1A2-substrate: 0.313
CYP2C19-inhibitor: 0.053 CYP2C19-substrate: 0.071
CYP2C9-inhibitor: 0.152 CYP2C9-substrate: 0.417
CYP2D6-inhibitor: 0.07 CYP2D6-substrate: 0.148
CYP3A4-inhibitor: 0.766 CYP3A4-substrate: 0.51

ADMET: Excretion

Clearance (CL): 3.568 Half-life (T1/2): 0.025

ADMET: Toxicity

hERG Blockers: 0.013 Human Hepatotoxicity (H-HT): 0.878
Drug-inuced Liver Injury (DILI): 0.969 AMES Toxicity: 0.027
Rat Oral Acute Toxicity: 0.971 Maximum Recommended Daily Dose: 0.371
Skin Sensitization: 0.016 Carcinogencity: 0.042
Eye Corrosion: 0.003 Eye Irritation: 0.007
Respiratory Toxicity: 0.012
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC006114 0.868 D01XWG 0.276
ENC006116 0.732 D01UBX 0.270
ENC006115 0.709 D07IPB 0.266
ENC006117 0.696 D0T5XN 0.262
ENC005885 0.545 D0Q0PR 0.260
ENC003348 0.545 D0T8EH 0.259
ENC005730 0.506 D0C9XJ 0.258
ENC005727 0.494 D07VLY 0.258
ENC005729 0.494 D03RTK 0.257
ENC002945 0.473 D0FX2Q 0.255
*Note: the compound similarity was calculated by RDKIT.